Li Kang Biomedical Co Ltd Net Asset Quality Index
Li Kang Biomedical Co Ltd net asset quality index. Li Kang Biomedical Co Ltd (6242) has a Net Asset Quality Index of 80.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$1.09 Billion minus total liabilities of NT$212.01 Million yields net assets of NT$881.47 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Li Kang Biomedical Co Ltd (6242) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Li Kang Biomedical Co Ltd (2002–2025)
Net asset quality index of Li Kang Biomedical Co Ltd from 2002 to 2025. This chart shows how Li Kang Biomedical Co Ltd's Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of March 2026, the index stands at 80.6%, representing net assets of NT$881.47 Million against total assets of NT$1.09 Billion TWD. See Li Kang Biomedical Co Ltd net assets for net asset value and shareholders' equity analysis.
Li Kang Biomedical Co Ltd Net Asset Quality Index by Year (2002–2025)
Li Kang Biomedical Co Ltd net asset quality index by year from 2002 to 2025. The table below presents the year-by-year Net Asset Quality Index for Li Kang Biomedical Co Ltd from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Li Kang Biomedical Co Ltd (6242) market capitalisation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 79.7% | NT$871.24 Million | NT$1.09 Billion | NT$221.82 Million | ▼ -2.9 pp |
| 2024 | 82.6% | NT$855.68 Million | NT$1.04 Billion | NT$179.93 Million | ▲ +6.4 pp |
| 2023 | 76.2% | NT$630.03 Million | NT$827.00 Million | NT$196.97 Million | ▼ -6.6 pp |
| 2022 | 82.8% | NT$570.14 Million | NT$688.84 Million | NT$118.70 Million | ▲ +2.9 pp |
| 2021 | 79.9% | NT$492.00 Million | NT$616.07 Million | NT$124.07 Million | ▲ +1.0 pp |
| 2020 | 78.8% | NT$508.30 Million | NT$644.77 Million | NT$136.46 Million | ▲ +1.7 pp |
| 2019 | 77.2% | NT$483.44 Million | NT$626.44 Million | NT$143.00 Million | ▲ +0.6 pp |
| 2018 | 76.6% | NT$466.92 Million | NT$609.85 Million | NT$142.93 Million | ▲ +1.8 pp |
| 2017 | 74.8% | NT$445.68 Million | NT$596.06 Million | NT$150.38 Million | ▲ +13.3 pp |
| 2016 | 61.4% | NT$340.80 Million | NT$554.77 Million | NT$213.96 Million | ▲ +8.2 pp |
| 2015 | 53.2% | NT$280.29 Million | NT$526.73 Million | NT$246.44 Million | ▼ -16.9 pp |
| 2014 | 70.1% | NT$227.44 Million | NT$324.37 Million | NT$96.93 Million | ▲ +48.4 pp |
| 2013 | 21.7% | NT$24.29 Million | NT$111.79 Million | NT$87.50 Million | ▼ -36.0 pp |
| 2012 | 57.7% | NT$85.12 Million | NT$147.57 Million | NT$62.45 Million | ▼ -9.8 pp |
| 2011 | 67.5% | NT$123.43 Million | NT$182.81 Million | NT$59.37 Million | ▼ -0.2 pp |
| 2010 | 67.8% | NT$104.31 Million | NT$153.96 Million | NT$49.65 Million | ▲ +16.9 pp |
| 2009 | 50.8% | NT$128.49 Million | NT$252.83 Million | NT$124.35 Million | ▲ +7.2 pp |
| 2008 | 43.6% | NT$191.32 Million | NT$438.89 Million | NT$247.58 Million | ▼ -15.0 pp |
| 2007 | 58.6% | NT$411.54 Million | NT$701.86 Million | NT$290.32 Million | ▲ +30.1 pp |
| 2006 | 28.5% | NT$215.94 Million | NT$757.63 Million | NT$541.69 Million | ▲ +0.3 pp |
| 2005 | 28.2% | NT$223.45 Million | NT$791.11 Million | NT$567.66 Million | ▼ -14.0 pp |
| 2004 | 42.2% | NT$323.44 Million | NT$766.35 Million | NT$442.91 Million | ▼ -1.7 pp |
| 2003 | 43.9% | NT$338.06 Million | NT$770.15 Million | NT$432.09 Million | ▼ -1.5 pp |
| 2002 | 45.4% | NT$347.64 Million | NT$765.96 Million | NT$418.31 Million | — |